Volume 98, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Reactivation of Chagas disease in the chronic phase may occur after solid organ transplantation, which may result in high parasitemia and severe clinical manifestations such as myocarditis and meningoencephalitis. The aim of the present study is to describe the prevalence of Chagas disease among solid organ–transplanted patients in a tertiary hospital from a nonendemic country. A cross-sectional study was performed at Vall d’Hebron University Hospital (Barcelona, Spain) from April to September 2016. Chagas disease screening was performed through serological tests in adult patients coming from endemic areas that had received solid organ transplantation and were being controlled in our hospital during the study period. Overall, 42 patients were included, 20 (47.6%) were male and median age was 50.5 (23–73) years. Transplanted organs were as follows: 18 kidneys, 17 lungs, and 7 livers. Three patients had Chagas disease, corresponding to a prevalence among this group of solid organ–transplanted patients of 7.1%. All three patients were born in Bolivia, had been diagnosed with Chagas disease and received specific treatment before the organ transplantation. We highly recommend providing screening tests for Chagas disease in patients with or candidates for solid organ transplantation coming from endemic areas, early treatment with benznidazole, and close follow-up to prevent clinical reactivations.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. World Health Organization, Chagas Disease (American trypanosomiasis). Available at: http://www.who.int. Accessed September 1, 2017.
  2. Schmunis GA, Yadon ZE, , 2010. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 115: 1421. [Google Scholar]
  3. Salvador F, 2014. Trypanosoma cruzi infection in a non-endemic country: epidemiological and clinical profile. Clin Microbiol Infect 20: 706712. [Google Scholar]
  4. Rassi A, Jr Rassi A, Marín-Neto JA, , 2010. Chagas disease. Lancet 375: 13881402. [Google Scholar]
  5. Bern C, , 2012. Chagas disease in the immunosuppressed host. Curr Opin Infect Dis 25: 450457. [Google Scholar]
  6. Lattes R, Lasala MB, , 2014. Chagas disease in the immunosuppressed patient. Clin Microbiol Infect 20: 300309. [Google Scholar]
  7. Riarte A, 1999. Chagas disease in patients with kidney transplants: 7 years of experience 1989–1996. Clin Infect Dis 29: 561567. [Google Scholar]
  8. Diez M, 2007. Usefulness of PCR strategies for early diagnosis of Chagas disease reactivation and treatment follow-up in heart transplantation. Am J Transplant 7: 16331640. [Google Scholar]
  9. Salvador F, Len O, Molina I, Sulleiro E, Sauleda S, Bilbao I, Castells L, Pont T, Gavaldà J, Pahissa A, , 2011. Safety of liver transplantation with Chagas disease-seropositive donors for seronegative recipients. Liver Transpl 17: 13041308. [Google Scholar]
  10. Jackson Y, Dang T, Schnetzler B, Pascual M, Meylan P, , 2011. Trypanosoma cruzi fatal reactivation in a heart transplant recipient in Switzerland. J Heart Lung Transplant 30: 484485. [Google Scholar]
  11. Salvador F, Sánchez-Montalvá A, Valerio L, Serre N, Roure S, Treviño B, Pou D, Sulleiro E, Bocanegra C, Molina I, , 2015. Immunosuppression and Chagas disease; experience from a non-endemic country. Clin Microbiol Infect 21: 854860. [Google Scholar]
  12. Chin-Hong PV, Schwartz BS, Bern C, Montgomery SP, Kontak S, Kubak B, Morris MI, Nowicki M, Wright C, Ison MG, , 2011. Screening and treatment of Chagas disease in organ transplant recipients in the United States: recommendations from the Chagas in transplant working group. Am J Transplant 11: 672680. [Google Scholar]
  13. Len O, Garzoni C, Lumbreras C, Molina I, Meije Y, Pahissa A, Grossi P, ESCMID Study Group of Infection in Compromised Hosts; , 2014. Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections. Clin Microbiol Infect 20 (Suppl 7): 1018. [Google Scholar]
  14. Pinazo MJ, 2011. Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. Transplant Rev (Orlando) 25: 91101. [Google Scholar]
  15. Consejo Interterritorial de Trasplantes de España, 2004. Criterios de selección del donante de órganos respecto a la transmisión de infecciones, 2nd edition. Available at: http://www.ont.es/infesp/DocumentosDeConsenso/infecciondonante.pdf. Accessed October 1, 2017.
  16. World Health Organization (WHO), 2002. Control of Chagas disease. World Health Organ Tech Rep Ser 905: 1109. [Google Scholar]
  17. Piron M, Fisa R, Casamitjana N, López-Chéjade P, Puig L, Vergés M, Gascón J, Gómez i Prat J, Portús M, Sauleda S, , 2007. Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Trop 103: 195200. [Google Scholar]
  18. Thambo S, Passalacqua W, Van Cauwelaert R, Lazcano F, , 1989. Chagas disease in patients with renal transplantation. Rev Med Chil 117: 1822. [Google Scholar]
  19. Boin ID, Boteon YL, Stucchi RS, Pereira MI, Portugal TC, Udo EY, , 2010. Serological profile of pretransplantation liver patients. Transplant Proc 42: 491493. [Google Scholar]
  20. Fitzpatrick MA, Caicedo JC, Stosor V, Ison MG, , 2010. Expanded infectious diseases screening program for Hispanic transplant candidates. Transpl Infect Dis 12: 336341. [Google Scholar]
  21. Rodríguez-Romo R, Morales-Buenrostro LE, Reyes PA, Gracida C, Medeiros M, Mancilla E, De Leo C, Alberú J, , 2013. Seroprevalence of Trypanosoma cruzi in kidney transplant donors and recipients in Mexico City. Transpl Infect Dis 15: 639644. [Google Scholar]
  22. Basile L, 2011. Chagas disease in European countries: the challenge of a surveilllance system. Euro Surveill 16: 19968. [Google Scholar]
  23. Riarte A, Luna C, Sinagra A, , 2000. Enfermedad de Chagas en el huésped trasplantado. Medicina (Buenos Aires) 60: 3132. [Google Scholar]
  24. Altclas J, Sinagra A, Dictar M, Luna C, Verón MT, De Rissio AM, García MM, Salgueira C, Riarte A, , 2005. Chagas disease in bone marrow transplantation: an approach to preemptive therapy. Bone Marrow Transplant 36: 123129. [Google Scholar]
  25. Jackson Y, Dang T, Schnetzler B, Pascual M, Meylan P, , 2011. Trypanosoma cruzi fatal reactivation in a heart transplant recipient in Switzerland. J Heart Lung Transplant 30: 484485. [Google Scholar]
  26. Campos FP, Pansard HM, Arantes LC, Rodrigues AT, Daubermann MF, Azambuja MF, Argenta LC, Silva LA, , 2016. A case of Chagas disease paniculitis after kidney transplantation. J Bras Nefrol 38: 127131. [Google Scholar]
  27. Cicora F, Escurra V, Bibolini J, Petroni J, González I, Roberti J, , 2014. Cerebral tripanosomiasis in a renal transplant recipient. Transpl Infect Dis 16: 813817. [Google Scholar]
  28. Campos SV, Strabelli TM, Amato Neto V, Silva CP, Bacal F, Bocchi EA, Stolf NA, , 2008. Risk factors for Chagas’ disease reactivation after heart transplantation. J Heart Lung Transplant 27: 597602. [Google Scholar]
  29. Bestetti RB, Souza TR, Lima MF, Theodoropoulos TA, Cordeiro JA, Burdmann EA, , 2007. Effects of a mycophenolate mofetil-based immunosuppressive regimen in Chagas’ heart transplant recipients. Transplantation 84: 441442. [Google Scholar]
  30. Requena-Méndez A, Albajar-Viñas P, Angheben A, Chiodini P, Gascón J, Muñoz J, Chagas Disease COHEMI Working Group; , 2014. Health policies to control Chagas disease transmission in European countries. PLoS Negl Trop Dis 8: e3245. [Google Scholar]

Data & Media loading...

  • Received : 20 Sep 2017
  • Accepted : 05 Nov 2017
  • Published online : 05 Feb 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error